Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis under normal and pathological conditions.

D Ribatti1, A Vacca, L Roncali

  • 1Istituto di Anatomia Umana Normale e di Istologia ed Embriologia, Università, Facoltà, Medica, Bari, Italy.

Haematologica
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surviving adversity: Exploring the presence of Lunularia cruciata (L.) Dum. on metal-polluted mining waste.

Plant biology (Stuttgart, Germany)·2024
Same author

Three is better than two: humoral response in allogeneic HSCT after the third BNT162b2 SARS-CoV-2 mRNA vaccine.

European review for medical and pharmacological sciences·2023
Same author

Pulmonary Embolism in COVID-19 Patients Is Not Related to a Deterioration of Tissue Oxygenation.

Advances in experimental medicine and biology·2022
Same author

Cardiovascular Risk Score and Pulmonary Gas Exchange in COVID-19 Patients Show No Correlation.

Advances in experimental medicine and biology·2022
Same author

Chronic graft vs. host disease and hypogammaglobulinemia predict a lower immunological response to the BNT162b2 mRNA COVID-19 vaccine after allogeneic hematopoietic stem cell transplantation.

European review for medical and pharmacological sciences·2022
Same author

Development of pectoral muscle atrophy in critically ill patients.

Medicina intensiva·2022
Same journal

Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.

Haematologica·2026
Same journal

Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a <i>post-hoc</i> analysis of the RIDTS trial.

Haematologica·2026
Same journal

Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series.

Haematologica·2026
Same journal

Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.

Haematologica·2026
Same journal

Reframing leukemia-niche interactions: the emerging role of the marrow adipocyte lineage.

Haematologica·2026
Same journal

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.

Haematologica·2026
See all related articles

Angiogenesis, the formation of new blood vessels, is crucial for development and disease. Researchers are exploring anti-angiogenic factors, like steroids, for potential tumor therapies.

Area of Science:

  • Biomedical Science
  • Cell Biology
  • Oncology

Background:

  • Angiogenesis, or new blood vessel generation, is vital in embryonic development and adult physiology and pathology.
  • Key angiogenic factors (e.g., FGF, TGF) have been identified, with sequences determined and genes cloned.
  • Tumor-induced angiogenesis is unique, persisting indefinitely without host or tumor eradication.

Purpose of the Study:

  • To review current knowledge and techniques for studying angiogenesis.
  • To highlight the distinct nature of tumor angiogenesis.
  • To introduce anti-angiogenic factors as a potential therapeutic strategy for cancer.

Main Methods:

  • In vivo investigation techniques include transparent chambers, corneal micropockets, chick chorioallantoic membrane assays, and polymer-based factor delivery.

Related Experiment Videos

  • In vitro methods involve cloning and long-term culture of capillary endothelial cells.
  • Identification and characterization of anti-angiogenic factors, including novel non-glucocorticoid steroids.

    • Main Results:

    • Established methods for studying angiogenesis in various biological contexts.
    • Demonstrated that tumor angiogenesis is a continuous, non-self-limiting process.
    • Identified novel anti-angiogenic steroids with potential therapeutic applications.

    Conclusions:

    • Angiogenesis is a fundamental biological process with implications in both normal development and disease.
    • Understanding the mechanisms of angiogenesis, particularly in tumors, is critical.
    • Anti-angiogenic therapies, especially those utilizing novel steroid compounds, represent a promising avenue for cancer treatment.